Dupilumab Use in Severe Epidermolysis Bullosa Simplex

This case report describes treatment with dupilumab in an infant patient with generalized severe epidermolysis bullosa simplex due to a pathogenic variant.

Corresponding Author: Christine Bodemer MD, PhD, Department of Dermatology and Reference Centre for Genodermatoses and Rare Skin Diseases, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique−Hôpitaux de Paris, France (christine.bodemer@aphp.fr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.